Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
13.48%
operating margin TTM
11.07%
revenue TTM
279.38 Million
revenue per share TTM
1.0$
valuation ratios | |
|---|---|
| pe ratio | 322.18 |
| peg ratio | 5.66 |
| price to book ratio | 15.20 |
| price to sales ratio | 44.39 |
| enterprise value multiple | 326.67 |
| price fair value | 15.20 |
profitability ratios | |
|---|---|
| gross profit margin | 98.44% |
| operating profit margin | 11.07% |
| pretax profit margin | 13.33% |
| net profit margin | 13.48% |
| return on assets | 3.22% |
| return on equity | 5.04% |
| return on capital employed | 3.17% |
liquidity ratio | |
|---|---|
| current ratio | 5.47 |
| quick ratio | 5.43 |
| cash ratio | 4.50 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 654.59 |
| operating cycle | 897.26 |
| days of payables outstanding | 2,960.62 |
| cash conversion cycle | -2,063.36 |
| receivables turnover | 1.50 |
| payables turnover | 0.12 |
| inventory turnover | 0.56 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.06 |
| debt equity ratio | 0.08 |
| long term debt to capitalization | 0.11 |
| total debt to capitalization | 0.08 |
| interest coverage | 10.20 |
| cash flow to debt ratio | -1.35 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.24 |
| cash per share | 2.22 |
| operating cash flow per share | -0.23 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -1.35 |
| short term coverage ratios | 2.57 |
| capital expenditure coverage ratio | -44.67 |
Frequently Asked Questions
When was the last time ImmunoGen, Inc. (NASDAQ:IMGN) reported earnings?
ImmunoGen, Inc. (IMGN) published its most recent earnings results on 02-11-2023.
What is ImmunoGen, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ImmunoGen, Inc. (NASDAQ:IMGN)'s trailing twelve months ROE is 5.04%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ImmunoGen, Inc. (IMGN) currently has a ROA of 3.22%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did IMGN's net profit margin stand at?
IMGN reported a profit margin of 13.48% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is IMGN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.47 in the most recent quarter. The quick ratio stood at 5.43, with a Debt/Eq ratio of 0.08.